BioNTech SE
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioNTech SE generated cash of $5,371,400,000, which is less than the previous year. Cash used in financing activities reached the amount of -$778,600,000 last year. Net change in cash is therefore -$2,211,400,000.
Cash Flow
| 2017 | -52.56M | -52.54M | -1.64M |
|---|---|---|---|
| 2018 | -58.18M | -67.14M | 365.17M |
| 2019 | -198.53M | -77.11M | 383.29M |
| 2020 | -13.47M | -144.84M | 894.72M |
| 2021 | 889.7M | -566.1M | 94.2M |
| 2022 | 13.57B | -35.3M | -1.41B |
| 2023 | 5.37B | -6.95B | -778.6M |
BNTX Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.87B | 1.69B | 1.21B | 519.14M | 411.49M | 172.10M | 303.68M |
Operating activities | |||||||
Net income | 1.18B | 12.95B | 15.04B | -145.80M | -179.44M | -47.66M | -85.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 183.4M | 123.3M | 75.2M | 38.74M | 33.89M | 21.98M | 10.52M |
Stock-based compensation expense | 51.4M | 108.6M | 93.9M | 32.1M | 30.23M | 0 | 5.90M |
| Deferred income tax benefit | 51.4M | 108.6M | 93.9M | 32.1M | 30.23M | 0 | 5.90M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 5.37B | 4.36B | -11.80B | -247.88M | 2.93M | -18.73M | -2.81M |
Inventories | 81.9M | 62.9M | -438.4M | -49.79M | -5.79M | -1.25M | -574K |
Accounts payable | 118.9M | 85.7M | 1.51B | 204.58M | -80.57M | -20.97M | -4.57M |
Cash generated by operating activities | 5.37B | 13.57B | 889.7M | -13.47M | -198.53M | -58.18M | -52.56M |
Investing activities | |||||||
Purchases Of Investments | -7.12B | -47.8M | -394.7M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -250.1M | -363.3M | -154M | -85.44M | -71.08M | -67.85M | -57.74M |
Acquisitions Net | -336.9M | 589.19K | -20.8M | -60.64M | -6.05M | 727.57K | 4.87M |
Cash generated by investing activities | -6.95B | -35.3M | -566.1M | -144.84M | -77.11M | -67.14M | -52.54M |
Financing activities | |||||||
Common Stock Issued | 0 | 110.5M | 160.9M | 753.00M | 375.4M | 361.72M | 0 |
Payments for dividends | 0 | -475.57M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -738.5M | -986.4M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -40.1M | -59.1M | -66.7M | -14.30M | 7.9M | -2.14M | -1.64M |
Cash used in financing activities | -778.6M | -1.41B | 94.2M | 894.72M | 383.29M | 365.17M | -1.64M |
Net Change In Cash | -2.21B | 12.18B | 482.5M | 691.06M | 107.65M | 239.38M | -131.57M |
Cash at end of period | 11.66B | 13.87B | 1.69B | 1.21B | 519.14M | 411.49M | 172.10M |
| Data source | Data source | Data source | Data source | Data source |